Spyre Therapeutics, Inc.

This study is testing an investigational drug called SPY002-072 to see if it can reduce disease activity in adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. It will compare the drug to a placebo in about 285 particip…

This study is testing several long-acting antibody treatments, both alone and in combinations, for adults with moderate to severe ulcerative colitis. The goal is to see if these treatments can control the disease by reducing inflammation and symptoms. The trial will involve 645 p…